| 000 | 01334 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512015845.0 | ||
| 264 | 0 | _c19891005 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0278-0232 | ||
| 024 | 7 |
_a10.1002/hon.2900070503 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJeffery, G M | |
| 245 | 0 | 0 |
_aA risk factor for relapse in Hodgkin's disease: female gender? _h[electronic resource] |
| 260 |
_bHematological oncology _c |
||
| 300 |
_a345-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHodgkin Disease _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMediastinal Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aColls, B M | |
| 700 | 1 | _aRobinson, B A | |
| 700 | 1 | _aFitzharris, B M | |
| 700 | 1 | _aAtkinson, C H | |
| 773 | 0 |
_tHematological oncology _gvol. 7 _gno. 5 _gp. 345-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hon.2900070503 _zAvailable from publisher's website |
| 999 |
_c2773497 _d2773497 |
||